People with severe mental illness are likely to die much earlier. Regular screening for heart disease risk is necessary for those with mental illness.
People with severe mental illness are at high risk of developing cardiovascular disease compared to the general population, according to an international study. The study led by King’s College London, shows that people with severe mental illness (SMI), including schizophrenia, bipolar disorder, and major depression, have a 53 percent higher risk of having cardiovascular disease than healthy controls, with a 78 percent higher risk of developing the cardiovascular disease over the longer term. Their risk of dying from the disease was also 85 percent higher than people of a similar age in the general population.
‘The use of antipsychotic drugs and higher body mass index are the factors that increase the risk of cardiovascular disease in people with severe mental illness.’
The findings of the published online in the World Psychiatry highlight the importance of regularly screening SMI patients for cardiovascular risk and also point towards a number of potentially modifiable risk factors.It is well documented that people with SMI die 10 to 15 years earlier than the general population, largely due to cardiovascular disease, including heart disease, heart attack and stroke.
This new study is the largest ever meta-analysis of SMI and cardiovascular disease, including over 3.2 million patients and more than 113 million people from the general population. The researchers examined 92 studies across four continents and 16 different countries, including the US, UK, France, Australia, and Sweden. Ten percent of people with SMI had cardiovascular disease, with rates slightly higher in schizophrenia (11.8 percent) and depression (11.7 percent) than bipolar disorder (8.4 percent), with a substantially increased risk of developing cardiovascular disease over time.
The researchers identified some important factors which increase the risk for cardiovascular disease, including antipsychotic use and higher body mass index. Based on these results, it is crucial that clinicians where possible choose antipsychotics with lower side effects related to weight gain, high blood pressure and glucose abnormalities.
Clinicians should also screen for emerging and existing cardiovascular diseases, as well as proactively managing risk factors such as weight and body mass index, according to the study authors.
Advertisement
’People with SMI die much earlier than those without these disorders, yet the majority of these premature deaths may be preventable with the care that prioritizes lifestyle changes, such as exercise, better nutrition and stopping smoking, along with cautious prescribing of antipsychotics.’
Advertisement